BOLTON SECURITIES CORPORATION’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BOLTON SECURITIES CORPORATION's BMY Position: Q2 2026 in Review
BOLTON SECURITIES CORPORATION increased its Bristol-Myers Squibb (BMY) stake by 96% in Q2 2026, buying an estimated $258K and bringing the position to 9,175 shares worth $529K. The position accounts for 0.02% of the portfolio, ranked #591.
BOLTON SECURITIES CORPORATION first reported a position in BMY in Q1 2025 and has held it in 4 quarters since. 2,542 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- BOLTON SECURITIES CORPORATION held 9,175 shares of Bristol-Myers Squibb worth $529K as of Q2 2026.
- BOLTON SECURITIES CORPORATION bought 4,488 Bristol-Myers Squibb shares in Q2 2026, an estimated $258K.
- Bristol-Myers Squibb made up 0.02% of BOLTON SECURITIES CORPORATION's portfolio in Q2 2026, its #591 holding.
- BOLTON SECURITIES CORPORATION first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 4 quarters since.
- 2,542 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on BOLTON SECURITIES CORPORATION's 13F filing for Q2 2026, filed 12 Nov 2026.